Free ACRP Clinical Study Protocols Question and Answers â Questions and Answers
Question 1: Profile of the investigational product that includes<br> Preâclinical and clinical trial experience to date<br> Method of action<br> ADME properties<br> Safety profile - what adverse events are expected?<br> Dosage<br> Contraindications<br> PI must be familiar with content
- Investigational new drug application
- Investigator's brochure (Correct answer)
- Case report form
- Essential documents
Correct answer: Investigator's brochure
The Investigator's Brochure is a comprehensive document prepared by the sponsor of a clinical trial. It provides detailed information about the investigational product being studied in the trial. The purpose of the Investigator's Brochure is to ensure that all investigators involved in the trial have the necessary information to conduct the study safely and effectively.
Question 2: â„ "Is intended as an implant and presents a potential for serious risk to the health, safety, or welfare of a subject"<br> â„ "Is purported or represented to be for use supporting or sustaining human life and presents a potential for serious risk to the health, safety, or welfare of a subject"<br> â„ "Is for a use of substantial importance in diagnosing, curing, mitigating, or treating disease, or otherwise preventing impairment of human health and presents a potential for serious risk to the health, safety, or welfare of a subject"<br> â„ "Otherwise presents a potential for serious risk to the health, safety, or welfare of a subject"
- Significant Risk Device (Correct answer)
- Investigational Product
- The Sponsor
- Submit Humanitarian Device Exemption
Correct answer: Significant Risk Device
In clinical trials involving Significant Risk Devices, sponsors must comply with specific regulations and obtain appropriate approvals before initiating the investigation. These devices are subject to stringent oversight to ensure the protection and safety of research subjects.
Question 3: Sponsor can transfer all or some<br> responsibilities of a trial to a CRO<br> Must be in writing<br> Ultimate responsibility for quality and<br> integrity of the trial data remains with<br> sponsor<br> CRO must comply with "sponsor" regulatory<br> obligations for responsibilities transferred
- Purpose of monitoring
- Transfer of obligations (Correct answer)
- Investigator's brochure
- Publication
Correct answer: Transfer of obligations
This refers to the process where a sponsor (the entity funding or initiating a clinical trial) can delegate some or all of the responsibilities associated with the trial to a Contract Research Organization (CRO).<br> The transfer of these responsibilities must be documented in writing, usually through a formal agreement or contract between the sponsor and the CRO.<br> Despite delegating certain tasks to the CRO, the ultimate responsibility for ensuring the quality and integrity of the trial data remains with the sponsor.<br> The CRO is also obligated to comply with the sponsor's regulatory requirements and standards for the responsibilities that have been transferred.
Question 4: â„ Education, credentials, training, and experience<br> - Background in clinical area<br> - Operational, regulatory, ethical training in conduct of clinical trials<br> - Certifications<br> â„ Association of Clinical Research Professionals (ACRP)<br> - 2 years of experience & passing exam<br> â„ Studyâspecific training<br> - Investigator meeting<br> - Initiation visit
- QA of Data
- QA of Study Personnel (Correct answer)
- Termination
- QA of Design
Correct answer: QA of Study Personnel
QA of study personnel involves assessing the performance, competence, and compliance of individuals involved in conducting the clinical trial.<br> This includes evaluating adherence to protocols, ethical standards, and regulatory requirements to ensure the quality and integrity of the research.
Question 5: â„ FDA Investigations Operational Manual for conducting inspections<br> â„ When inspector arrives:<br> - Verify their credentials<br> - Record inspector's badge #<br> - Obtain a copy of 482<br> â„ Inspector's Assignment
- Opening Conference
- The Inspection (Correct answer)
- Introduction
- Closing Conference
Correct answer: The Inspection
These steps and considerations are crucial for facilities subject to FDA inspections to ensure compliance with regulatory standards and facilitate a smooth and efficient inspection process. Understanding and adhering to FDA inspection procedures contribute to maintaining quality and regulatory compliance within the industry.
Question 6: Promote & protect public health by helping safe & effective drugs reach market<br> â„ Monitor for continued safety after approved<br> â„ Enforce regulations regarding:<br> - Testing of drugs & medical devices in humans<br> - Manufacturing process of drugs & devices<br> - Sanitation of foods<br> - Use of pesticides<br> - Veterinary medicine C
- The Inspection
- FDA Regulations Enforcement
- The Inspection
- FDA Mission (Correct answer)
Correct answer: FDA Mission
Understanding the FDA's mission and regulatory role is essential for stakeholders in the pharmaceutical, medical device, food, and cosmetics industries to comply with standards and ensure the safety and efficacy of products reaching consumers.
Question 7: Should be chosen based on:<br> - Clinical expertise<br> - Availability<br> - Willingness to participate in research<br> â„ Reimbursement based on usual fee + 10%<br> â„ May be able to get at reduced rate<br> - i.e. volume discount<br> â„ Only enter into budget once rate agreed upon by both parties<br> - Written agreement of rates/service fees<br> - Do not estimate!!
- CRO
- Budgeting Ancillary Services
- QA Of Data
- CRA (Correct answer)
Correct answer: CRA
Understanding the role of CRAs and budgeting considerations is essential for effective management and coordination of clinical research activities.
Question 8: Ensuring QA of inputs ultimately ensures QA of outputs... the data<br> â„ Audits should occur to ensure integrity of data<br> â„ Where does data come from?<br> â„ When should final QA inspection occur?
- In the Beginning....
- Lead Data Manager
- Purpose of Monitoring
- QA of Data (Correct answer)
Correct answer: QA of Data
Maintaining QA of data inputs is essential for generating reliable and valid outcomes in clinical research studies.
Question 9: Standard Operating Procedures (SOPs)
- â„ Provide consistency & quality in service to customers<br> â„ Improve efficiency<br> â„ Facilitates training of new staff<br> â„ Ensures compliance with regulations (Correct answer)
- Guidance documents for conduct of clinical research<br> - Standards that govern how site operates<br> â„ FDA requirement<br> â„ Must be followed exactly
- Commitment & motivation<br> â„ Clinical trial competencies<br> â„ Understanding/evaluating clinical trial industry & related affiliations<br> â„ Recruiting, hiring, & maintaining study personnel<br> â„ Obtaining proper training & credentialing as researchers<br> â„ Developing SOPs
- Issues<br> - Recruitment<br> - Scheduling<br> - Ongoing participants<br> - Adverse events<br> - Inclusion/exclusion criteria<br> - Medical opinions or advice<br> - Documentation
Correct answer: â„ Provide consistency & quality in service to customers<br> â„ Improve efficiency<br> â„ Facilitates training of new staff<br> â„ Ensures compliance with regulations
SOPs serve as guidance documents for the conduct of clinical research, outlining the standards and procedures that govern site operations. They are typically required by regulatory bodies such as the FDA and must be followed precisely to ensure compliance and consistency in research practices.<br> Issues that may be addressed in SOPs include recruitment procedures, scheduling protocols, ongoing participant management, management of adverse events, adherence to inclusion/exclusion criteria, handling of medical opinions or advice, and documentation requirements.<br> Maintaining and adhering to SOPs is crucial for ensuring the integrity, quality, and regulatory compliance of clinical research activities.
Question 10: Track revenues earned exactly<br> - Create spreadsheet of study patient activity<br> â„ Provides view of study progress<br> â„ Include amount earned, amount invoiced, amount received, & summary<br> â„ Things that can affect payment:<br> - Completed case report forms<br> - Amount of data retrieved by monitor
- Line Of Credit
- Managing Cash
- Channel Of Distribution
- Managing Accounts Receivable (Correct answer)
Correct answer: Managing Accounts Receivable
Managing accounts receivable is essential for maintaining financial stability and ensuring that all revenues and payments related to clinical trials are accurately tracked and managed.
Question 11: A clinical trial being conducted to confirm the safety and tolerability of a new anti-emetic IP would be considered what phase of clinical study?
- Any additional risks posed by study requirements (additional imaging, blood draws, ect.)<br> All associated risk/side effects of the investigational product, combination of IP with current standard treatment, and current stand treatment associated with the trial
- The informed consent contains a section that states the person/persons to contact for further information regarding the trial and the rights of trial subjects, and specifically who to contact in the event of trial-related injury.
- Phase I Trial<br> Phase I trials usually have non-therapeutic objectives Are intended to determine the tolerability of dose ranges for future trials Determine the nature of adverse events that may be expected (Correct answer)
- Phase I trials are primarily involved with PK sampling<br> Dose escalation are primarily done in Phase I studies
Correct answer: Phase I Trial<br> Phase I trials usually have non-therapeutic objectives Are intended to determine the tolerability of dose ranges for future trials Determine the nature of adverse events that may be expected
Phase I trials are critical for establishing the initial safety profile and pharmacokinetic properties of a new investigational product before proceeding to later phases of clinical development.
Free ACRP Clinical Study Protocols Question and Answers
Profile of the investigational product that includes
Preâclinical and clinical trial experience to date
Method of action
ADME properties
Safety profile - what adverse events are expected?
Dosage
Contraindications
PI must be familiar with content